Show simple item record

dc.contributor.authorSilva, ANS
dc.contributor.authorSaito, Y
dc.contributor.authorYoshikawa, T
dc.contributor.authorOshima, T
dc.contributor.authorHayden, JD
dc.contributor.authorOosting, J
dc.contributor.authorEarle, S
dc.contributor.authorHewitt, LC
dc.contributor.authorSlaney, HL
dc.contributor.authorWright, A
dc.contributor.authorInam, I
dc.contributor.authorLangley, RE
dc.contributor.authorAllum, W
dc.contributor.authorNankivell, MG
dc.contributor.authorHutchins, G
dc.contributor.authorCunningham, D
dc.contributor.authorGrabsch, HI
dc.date.accessioned2022-05-10T10:25:19Z
dc.date.available2022-05-10T10:25:19Z
dc.identifier.citationThe British journal of surgery, 2022, 109 (3), pp. 291 - 297en
dc.identifier.issn0007-1323
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5120
dc.identifier.eissn1365-2168en_US
dc.identifier.eissn1365-2168
dc.identifier.doi10.1093/bjs/znab460en_US
dc.identifier.doi10.1093/bjs/znab460
dc.description.abstract<h4>Background</h4>Patients with Epstein-Barr virus-positive gastric cancers or those with microsatellite instability appear to have a favourable prognosis. However, the prognostic value of the chromosomal status (chromosome-stable (CS) versus chromosomal instable (CIN)) remains unclear in gastric cancer.<h4>Methods</h4>Gene copy number aberrations (CNAs) were determined in 16 CIN-associated genes in a retrospective study including test and validation cohorts of patients with gastric cancer. Patients were stratified into CS (no CNA), CINlow (1-2 CNAs) or CINhigh (3 or more CNAs). The relationship between chromosomal status, clinicopathological variables, and overall survival (OS) was analysed. The relationship between chromosomal status, p53 expression, and tumour infiltrating immune cells was also assessed and validated externally.<h4>Results</h4>The test and validation cohorts included 206 and 748 patients, respectively. CINlow and CINhigh were seen in 35.0 and 15.0 per cent of patients, respectively, in the test cohort, and 48.5 and 20.7 per cent in the validation cohort. Patients with CINhigh gastric cancer had the poorest OS in the test and validation cohorts. In multivariable analysis, CINlow, CINhigh and pTNM stage III-IV (P < 0.001) were independently associated with poor OS. CIN was associated with high p53 expression and low immune cell infiltration.<h4>Conclusion</h4>CIN may be a potential new prognostic biomarker independent of pTNM stage in gastric cancer. Patients with gastric cancer demonstrating CIN appear to be immunosuppressed, which might represent one of the underlying mechanisms explaining the poor survival and may help guide future therapeutic decisions.en_US
dc.formatPrinten_US
dc.format.extent291 - 297en_US
dc.languageengen_US
dc.language.isoengen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.subjectHumansen_US
dc.subjectHerpesvirus 4, Humanen_US
dc.subjectAdenocarcinomaen_US
dc.subjectStomach Neoplasmsen_US
dc.subjectChromosomal Instabilityen_US
dc.subjectNeoplasm Stagingen_US
dc.subjectPrognosisen_US
dc.subjectRetrospective Studiesen_US
dc.subjectImmunocompromised Hosten_US
dc.subjectGene Dosageen_US
dc.subjectMutationen_US
dc.subjectGenes, p53en_US
dc.subjectAgeden_US
dc.subjectMiddle Ageden_US
dc.subjectFemaleen_US
dc.subjectMaleen_US
dc.subjectBiomarkers, Tumoren_US
dc.titleIncreasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.en
dc.typeJournal Article
dcterms.dateAccepted2021-12-09
rioxxterms.versionVoRen
rioxxterms.versionofrecord10.1093/bjs/znab460en
dc.relation.isPartOfThe British journal of surgeryen_US
pubs.issue3en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine (RMH Smith Cunningham)/Medicine (RMH Smith Cunningham) (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublisheden_US
pubs.volume109en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMedicine (RMH Smith Cunningham)
dc.contributor.icrauthorCunningham, David


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/